Order Revofil® Aquashine PTX for Clinics

Revofil® Aquashine PTX is a sterile, clear injectable gel supplied as one 2 mL pre-filled syringe for professional intradermal use. Licensed clinics, med spas, and healthcare professionals can order the Revofil Aquashine PTX 1 pre-filled syringe for skin-quality protocols that require a soft hyaluronic acid preparation with peptide support. The 15 mg/mL hyaluronic acid concentration and single-syringe format help teams plan treatment-room use, documentation, and inventory control.

This preparation is used by trained clinicians in aesthetic workflows focused on hydration, texture, tone, and elasticity rather than large-volume structural augmentation. It is intended for professional administration with appropriate aseptic technique, patient assessment, and post-treatment monitoring.

Format, Strength, and Clinic Ordering

Each unit contains one factory-filled 2 mL syringe of clear gel. The labeled hyaluronic acid concentration is 15 mg/mL, and the syringe is supplied in a sterile blister for single-patient use. Clinics that need the single-unit configuration can align purchasing records, lot tracking, and room stocking around SKU 88748.

Current Revofil Aquashine PTX price information is available to signed-in clinic accounts. Account-based purchasing helps practices review the pack configuration, quantity requirements, and procurement documentation before placing an order. For broader planning across similar products, the Revofil brand range can help teams keep related HA and skin-booster items grouped by manufacturer.

Quick tip: Match the single-syringe quantity to the clinical protocol and keep the carton label available for lot and expiry documentation.

What Revofil Aquashine PTX Is

Revofil Aquashine PTX is a soft-gel injectable used in professional skin-booster and mesotherapy-style programs. In this context, a skin booster is an intradermal injectable chosen for skin quality support, including hydration and surface texture appearance, rather than deep contouring or heavy lift. The gel’s rheology supports controlled microdeposition across wider treatment fields when used by experienced injectors.

The product combines a hyaluronic acid matrix with a peptide and biomimetic peptide complex. Hyaluronic acid binds water and provides a smooth injectable substrate. The peptide components are included to support extracellular matrix activity, which is relevant to protocols aimed at skin architecture and elasticity. For a broader ingredient discussion within this product family, see the clinical article on Revofil filler ingredients.

Aquashine PTX may be described in practice as a dermal filler or skin booster, depending on how a clinic categorizes its injectable portfolio. For procurement clarity, this unit is best identified as Revofil® Aquashine PTX, 15 mg/mL, one 2 mL pre-filled syringe.

Professional Applications and Protocol Fit

Clinicians use this gel for skin-quality maintenance across common aesthetic areas such as the face, neck, and selected body zones. It fits microinjection and microdroplet placement plans where a soft, even intradermal profile is desired. Placement depth, pattern, cadence, and session spacing should be determined by the treating professional after assessment of skin characteristics, anatomy, prior procedures, and treatment goals.

Within clinic workflows, Aquashine PTX can be scheduled as part of staged aesthetic care. Practices may coordinate skin-booster sessions with energy-based treatments, neuromodulator appointments, or other injectable services when clinically appropriate. The key operational value is consistency: one 2 mL syringe supports predictable set-up, measured use, and clear inventory reconciliation after the appointment.

Clinics building broader service lines can place this item within skin boosters or related mesotherapy products. These categories are useful for staff who reorder by procedure type rather than by brand name alone.

Key Features for Treatment Rooms

• One sterile pre-filled syringe containing 2 mL of gel.
• Hyaluronic acid concentration of 15 mg/mL.
• Clear, colorless soft-gel preparation.
• Designed for professional intradermal administration.
• Peptide and biomimetic peptide complex for matrix-supporting protocols.
• Soft rheology suited to controlled microdeposition.
• Factory-sealed blister format for procedural set-up.
• Single-patient use format supporting lot and expiry traceability.

The syringe presentation reduces preparation steps compared with products that require reconstitution or transfer before use. It also helps clinical staff standardize consumable pull lists, procedure-room checks, and post-session inventory notes.

Composition and Mechanism Considerations

The Aquashine PTX hyaluronic acid matrix provides moisture-binding characteristics and a smooth carrier for intradermal placement. Hyaluronic acid is widely used in aesthetic medicine because it attracts and retains water within tissue. In skin-booster protocols, the objective is generally a hydrated, more uniform skin-quality appearance rather than major projection or contour change.

The peptide blend differentiates this product from simple HA-only preparations. Peptides are included to support activity relevant to collagen and elastin network dynamics. These mechanisms should be discussed in clinic-facing terms without promising uniform patient outcomes, since response depends on skin condition, technique, treatment interval, and the broader aesthetic plan.

For general background on HA in aesthetic practice, the article on hyaluronic acid in aesthetic medicine may help teams brief new staff on why HA-based injectables occupy different roles across fillers, boosters, and mesotherapy products.

Benefits in Practice

The 2 mL syringe can be useful when a clinician plans wider-field skin-quality coverage. A single unit may reduce interruptions during a procedure compared with smaller presentations, although actual use depends on the treatment plan and professional judgment. The calibrated syringe feel also supports steady extrusion, which matters when placing small aliquots across a mapped area.

For clinics with multiple injectors, standardizing a pre-filled format can improve consistency in room preparation and documentation. Staff can record the same product name, concentration, syringe volume, lot number, and expiry date across appointment notes and purchasing systems. This reduces ambiguity when reviewing outcomes, planning repeat sessions, or auditing inventory movement.

Why it matters: Clear product identification helps prevent confusion between single-syringe and multi-syringe Aquashine PTX configurations.

Packaging, Labeling, and Inventory Control

This unit is supplied as one sterile pre-filled syringe in a sealed blister. The carton and primary labeling provide the lot number and expiry date for traceability. Clinics should retain relevant package information according to internal policy, especially when product use must be linked to a patient chart, treatment room, injector, or purchase order.

Because this is a professional injectable, storage, handling, and preparation should follow the product label and clinic protocol. Staff should inspect the packaging before use, maintain aseptic technique, and avoid using a syringe if sterility or integrity is in question. Temperature-controlled handling when required and tracked US delivery can support receiving workflows for clinics managing multiple aesthetic inventory classes.

Teams that maintain broader injectable inventories may also organize Aquashine PTX alongside skin booster education and category content so purchasing and clinical staff use consistent terminology across training, ordering, and treatment planning.

Safety, Reactions, and Professional Precautions

Expected transient injection-site reactions may include swelling, redness, bruising, tenderness, and localized discomfort. These reactions are common considerations with intradermal injectable gels and should be discussed during consent and post-care planning. Clinicians should evaluate patient history, skin status, prior aesthetic treatments, and any contraindication concerns before selecting a protocol.

Professional precautions include using aseptic technique, appropriate injection depth, suitable needle or cannula selection, and careful anatomic assessment. Treatment should not proceed through infected, inflamed, or compromised skin. Clinics should also have procedures for recognizing and managing unexpected inflammatory responses, persistent nodules, vascular compromise concerns, hypersensitivity, or other adverse events.

Use of Aquashine PTX should remain within the clinician’s training and the product’s professional-use context. Staff should not substitute products, alter handling steps, or combine procedures without clinical authorization. When protocols involve multiple modalities, sequencing should be planned by the treating professional to reduce avoidable irritation and support appropriate monitoring.

How Clinics Can Order Aquashine PTX Online

Licensed clinic accounts can order Aquashine PTX online by selecting the Revofil® Aquashine PTX single-syringe unit and choosing the quantity needed for scheduled procedures or inventory replenishment. Account review supports professional-use ordering, product documentation, and reliable US logistics for clinic receiving teams.

Before purchasing, confirm the required configuration: one pre-filled syringe, 2 mL content, 15 mg/mL hyaluronic acid, SKU 88748. This helps avoid mixing purchase requests with the two-syringe configuration or other Aquashine variants. For practices anticipating higher case volume or multi-visit scheduling, the Aquashine PTX two-syringe pack may be more practical.

Procurement teams should coordinate order quantities with appointment volume, storage capacity, expiration management, and injector preference. A clear receiving process helps staff reconcile delivered units against purchase orders and place product into the correct clinical inventory location.

Related Revofil and Aquashine Options

Clinics often evaluate Aquashine PTX alongside other Revofil skin-quality products to match product handling with protocol goals. Revofil Aquashine Soft Filler is another 15 mg/mL, 2 mL pre-filled syringe option within the Aquashine family. It may be considered when a clinic’s formulary separates general soft-filler use from PTX-specific protocols.

Revofil Aquashine BR Soft Filler provides another adjacent single-syringe choice for practices that stock multiple Aquashine formulations. Selecting among these products should be based on clinician training, desired handling characteristics, documented protocol, and the patient-specific assessment performed in practice.

For broader portfolio decisions, teams can also review the article on Revofil and Juvederm selection considerations. Product comparisons should support formulary planning, not replace injector judgment or product-specific training.

Professional Documentation and Receiving Workflow

Revofil Aquashine PTX 1 syringe should be documented using the full product name, concentration, volume, lot number, expiry date, and administration record required by clinic policy. Consistent documentation supports inventory audits, adverse-event review, and continuity when multiple injectors treat within the same clinic network.

Receiving teams should verify that the delivered item matches the purchase order before placing it into active stock. Packaging should remain intact until treatment-room preparation. If a clinic uses centralized purchasing for multiple locations, internal transfer records should preserve lot and expiry visibility from receiving through final use.

Clinical leads may also define substitution rules in advance. If the exact configuration is not appropriate for a planned protocol, approval should come from the responsible clinician rather than from procurement staff alone. This keeps purchasing decisions aligned with treatment technique, product handling, and patient safety expectations.

Authoritative Sources

For safety and procedural context, clinics should rely on the product label, manufacturer materials, and professional training. General regulatory and patient-safety resources on injectable fillers can help support clinic policies, but they should not replace product-specific instructions or clinical judgment.

• Use current product labeling and package materials for storage, handling, lot, and expiry details.
• Use clinic medical protocols for consent, contraindication screening, adverse-event escalation, and documentation.
• Use professional injector training for anatomy, injection depth, sequencing, and post-procedure monitoring.

This content is for informational purposes only and is not a substitute for professional medical advice.